Aripiprazole is associated with early onset of Tardive Dyskinesia like presentation in a patient with ABI and psychosis

Brain Injury

Volumn 22, Issue 1, 2008, Pages 99-102

  Zaidi, Syed Habib Haider ^a   Faruqui, Rafey A ^a  

^a ST ANDREW S HOSPITAL   (United Kingdom)

Author keywords

Acquired brain injury (ABI); Aripiprazole; Side effects; Tardive Dyskinesia; Treatment of psychosis

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; QUETIAPINE; RISPERIDONE;

ADULT; AKATHISIA; ARTICLE; BRAIN INJURY; CASE REPORT; COGNITIVE DEFECT; COMMUNICATION DISORDER; DRUG DOSE TITRATION; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; INVOLUNTARY MOVEMENT; MALE; PATIENT MONITORING; PSYCHOSIS; TARDIVE DYSKINESIA;

EID: 38049146178     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.1080/02699050701822493     Document Type: Article

References (20)

1. Semple, D., Smyth, R., Burns, J., Darjee, R. and Mclntosh, A. (2005) Symptoms of psychiatric illness, schizophrenia and related psychosis. Oxford handbook of psychiatry, pp. 90-210. Oxford University Press Inc, New York
2. Margolese, HC, Chouinard, G. and Kolivakis, TT (2005) Tardive Dyskinesia in the era of typical and atypical antipsychotics. Canadian Journal of Psychiatry, 50, pp. 703-714.
3. Gelder, M., Harrison, P. and Cowen, P. (2006) Drugs and other physical treatments. Shorter Oxford textbook of psychiatry, p. 534. Oxford University Press Inc, New York
4. Kane, JM (1995) Tardivedyskinesia: Epidemiological and clinical presentation. Psychopharmacology: The fourth generation of progress, pp. 1485-1495. Raven Press Ltd, New York
5. Glazer, WM, Morgenstern, H. and Doucette, JT (1993) Predicting the long term risk of tardive dyskinesia in outpatients maintained on neuroleptic medication. Journal of Clinical Psychiatry, 54, pp. 133-139.
6. Jeste, DV (2000) Tardive dyskinesia in older patients. Journal of Clinical Psychiatry, 61, pp. 27-32.
7. Llorca, PM, Chereau, I., Bayle, FJ and Lancon, C. (2002) Tardive dyskinesia and antipsychotics: A review. European Psychiatry, 17, pp. 129-138.
8. Barnes, TRE (1989) A rating scale for drug -induced akathisia. British Journal of Psychiatry, 154, pp. 672-676.
9. Simpson, GN and Angus, JWS (1970) A rating scale for extra pyramidal side effects. Acta Psychiatrica Scandinavica, 212, pp. 11-19.
10. Guy, W. (1976) ECDEU assessment manual for psychopharmacology., US Department of Health, Education and Welfare, Washington DC
11. Gervin, M. and Barnes, TRE (2000) Assessment of drug-related movement disorders in schizophrenia. Advanced Psychiatric Treatment, 6, pp. 332-341.
12. Lane, RD, Glazer, WM, Hansen, TE, Berman, WH and Kramer, S. (1985) Assessment of tardive dyskinesia using the abnormal involuntary movement scale. Journal of Nervous and Mental Disease, 173, pp. 353-357.
13. Munetz, MR and Benjamin, S. (1988) How to examine patients using the abnormal involuntary movement scale. Hospital and Community Psychiatry, 39, pp. 1172-1177.
14. Schooler, NR and Kane, JM (1982) Research diagnosis for Tardive Dyskinesia. Archives of General Psychiatry, 39, pp. 486-487.
15. Kane, JM, Jeste, DV, Barnes, TRE, Casey, DE, Cole, JO, Davis, JM, Gualtier, CT, Schooler, NR, Sprague, RL and Wettstein, RM (1992) American Psychiatric Association. Tardive Dyskinesia: A task force report of the American Psychiatric Association, APA, Washington, DC
16. Glazer, W. (2000) Expected incidence of tardive dyskinesia associated atypical antipsychotics. Journal of Clinical Psychiatry, 61, pp. 21-26.
17. Harrison, T Swainston and Perry, CM (2004) Aripiprazole: A review of its use in schizophrenia and schizoaffective disorder. Drugs, 64, pp. 1715-1736.
18. British Medical Association & Royal Pharmaceutical Society of Great Britain (2007)BMJ Publishing Group Ltd, London
19. Tarsy, D. and Baldessarini, RJ (2006) Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?. Movement Disorder, 21, pp. 589-598.
20. Glazer, WM Jeste, Morgenstern, H., Politz, JA and Yeung, PP Rarity of tardive dyskinesia with quetiapine treatment of psychotic disorders in the elderly. The 38th Annual meeting of the American College of Neuropsychopharmacology Scientific book of abstracts, p. 142, pp. 12-16.